ABBV 3Q22 Mavyret sales=$383M, -4% QoQ, -10% YoY: https://news.abbvie.com/news/press-releases/abbvie-reports-third-quarter-2022-financial-results.htm The geographic breakdown was: US $190M; ex-US $193M.